Rearrangements of IGH, TCRD and TCRG genes as clonality marker of childhood acute lymphoblastic leukemia

Experimental Oncology

Volumn 27, Issue 4, 2005, Pages 319-324

  Meleshko, A N ^a   Lipay, N V ^a   Stasevich, I V ^a   Potapnev, M P ^a  

^a Belarusian Research Center for Pediatric Oncology and Hematology   (Belarus)

Author keywords

Acute lymphoblastic leukemia (ALL); Childhood ALL; Immunoglobulin and T cells receptor rearragements; Leukemic cell clonality; Polymerase chain reaction

Indexed keywords

DNA; IMMUNOGLOBULIN; IMMUNOGLOBULIN HEAVY CHAIN; T LYMPHOCYTE RECEPTOR;

ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CLONAL VARIATION; GENE; GENE REARRANGEMENT; HETERODUPLEX ANALYSIS; HUMAN; IGH GENE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TCRD GENE; TCRG GENE;

CHILD; CLONE CELLS; DNA PRIMERS; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GENE REARRANGEMENT, DELTA-CHAIN T-CELL ANTIGEN RECEPTOR; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; POLYMERASE CHAIN REACTION;

EID: 31344446387     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. th edition. Philadelphia: WB Saunders Company, 1996: 83-130.
2. Borst J, Brouns GS, de Vries E, Verschuren MC, Mason DY, van Dongen JJ. Antigen receptors on T and B lymphocytes: parallels in organization and function. Immunol Rev 1993; 132: 49.
3. Szczepański T, Willemse JM, Kamps WA, van Wering ER, Langerak AW, van Dongen JJM. Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: proposal for an easy strategy. Med Pediatr Oncol 2001; 36: 352-8.
4. Moreira I, Foroni L. Heterogeneity of VH-JH gene rearrangement patterns: an insight into the biology of B cell precursor ALL. Leukemia 2001; 15: 1527-36.
5. Szczepanski T, Pongers-Willemse MJ, Langerak AW, Harts WA, Wijkhuijs AJ, van Wering ER, van Dongen JJ. Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant DH6-19 and DH7-27 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor αβ lineage. Blood 1999; 93: 4079-85.
6. Szczepański T, Beishuizen A, Pongers-Willemse MJ, Hählen K, van Wering ER, Wijkhuijs JM, Tibbe GJM, De Bruijn MAC, van Dongen JJM. Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease. Leukemia 1999; 13: 196-205.
7. Krejci O, Prouzova Z, Horvath O, Trka J, Hrusak O. Cutting edge: TCRδ gene is frequently rearranged in adult B lymphocytes. J Immunol 2003; 171: 524-7.
8. LeBien TW, Elstrom RL, Moseley M, Kersey JH, Griesinger F. Analysis of immunoglobulin and T-cell receptor gene rearrangements in human fetal bone marrow B lineage cells. Blood 1990; 76: 1196-200.
9. Van Dongen JJM, Langerak AW. Immuinoglobulin and T-cell receptor gene rearrangements. In: Childhood Leukemias. Pui C-H. Ed. NY, Cambridge University Press, 1999: 288-312.
10. Sanchez M-L, Almeida J, Gonzalez D. Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone. Blood 2003; 102: 2994-3002.
11. Szczepański T, Orfao A, van der Velden, San Miguel JS, van Dongen JJM. Minimal residual disease in leukaemia patients. Lancet Oncol 2001; 2: 409-17.
12. Chim JC, Coyle LA, Yaxley JC, Cole-Sinclair MF, Cannell PK, Hoffbrand VA, Foroni L. The use of IgH fingerprinting and ASO-dependent PCR for the investigation of residual disease (MRD) in ALL. Br J of Haematol 1996; 92: 104-15.
13. Sykes PJ, Snell LE, Brisco MJ, Neoh SH, Hughes E, Dolman G, Peng LM, Bennett A, Toogood I, Morley AA. The use of monoclonal gene rearrangement for detection of minimal residual disease in acute lymphoblastic leukemia of childhood. Leukemia 1997; 11: 153-8.
14. Knechtli CJ, Goulden NJ, Hancock JP, Grandage VL, Harris EL, Garland RJ, Jones CG, Rowbottom AW, Hunt LP, Green AF, Clarke E, Lankester AW, Cornish JM, Pamphilon DH, Steward CG, Oakhill A. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 1998; 92: 4072-9.
15. Mitterbauer-Hohendanner G, Mannhalter C, Winkler K, Mitterbauer M, Skrabs C, Chott A, Simonitsch-Klupp I, Gleiss A, Lechner K, Jaeger U. Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL). Leukemia 2004; 18: 1102-7.
16. Sandberg Y, Heule F, Lam K, Lugtenburg PJ, Wolvers-Tettero IL, van Dongen JJ, Langerak AW. Molecular immunoglobulin/T-cell receptor clonality analysis in cutaneous lymphoproliferations. Experience with the BIOMED-2 standardized polymerase chain reaction protocol. Haematologica 2003; 88: 659-70.
17. Iavorkovskii LI. Gene rearrangement of immunoglobulins and of the T-cell receptor for antigens and its significance in the diagnosis of lymphoproliferative diseases. Exp Oncol 1988; 10: 3-10 (In Russian).
18. Harbott J, Viehmann S, Borkhardt A, Henze G, Lampert F. Incidence of TEL-AML1 fusion gene analyzed consecutively in children with acute lymphoblastic leukemia in relapse. Blood 1997; 90: 4933-7.
19. Pongers-Willemse MJ, Seriu T, Stolz F, d'Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grumayer ER, Biondi A, San Miguel JF, van Dongen JJ. Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1dele-tions as PCR targets: report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 110-8.
20. Gameiro P, Mortuza FY, Hoffband V. Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor γ and δ gene rearrangements. Haematologica 2002; 87: 1126-34.
21. Theriault C, Galoin S, Valmary S, Selves J, Lamant L, Roda D, Rigal-Huguet F, Brousset P, Delsol G, Al Saati T. PCR analysis of immunoglobulin heavy chain (IgH) and TcR-g chain gene rearrangements in the diagnosis of lymphoproliferative disorders: results of a study of 525 cases. Mod Pathol 2000; 13: 1269-79.
22. Langerak AW, Szczepański T, van der Burg M, Wolvers-Tettero ILM, van Dongen JJM. Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations. Leukemia 1997; 11: 2192-9.
23. Meleshko AN, Potapnev MP. Detection of rearranged immunoglobulin and T-cell receptor genes as a method for characterization of tumor cell clonality in acute lymphoblast leukemia in children. Klin Lab Diagn 2004; 4: 19-22 (In Russian).
24. Szczepański T, Langerak AW, Willemse MJ, Wolvers-Tettero ILM, van Dongen JJM. T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect "end-stage" recombinationts: implication for minimal residual disease monitoring. Leukemia 2000; 14: 1208-14.
25. Szczepański T, Langerak AW, Willemse MJ, Wolvers-Tettero ILM, van Dongen JJM. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implication for minimal residual disease. Leukemia 1998; 12: 1081-8.
26. de Haas V, Verhagen OJHM, von dem Borne AEGK, Kroes W, van den Berg H, van der School CE. Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy. Leukemia 2001; 15: 134-40.
27. Green E, McConville CM, Powell JE, Mann JR, Darbyshire PJ, Malcolm A, Taylor R, Stankovic T. Clonal diversity of Ig and T-cell-receptor gene rearrangements identifies a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse. Blood 1998; 92: 952-8.
28. Szczepański T, Willemse MJ, Brinkhof B, van Wering ER, van der Burg M, van Dongen JJM. Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease. Blood 2002; 99: 2315-23.
29. Szczepanski T, Willemse MJ, van Weerden JF, Kamps WA, van Dongen JJM. Precursor-B-ALL with DH-JH gene rearrangements have an immature immunogenotype with a high frequence of oligoclonality and hyperploidy of chromosome 14. Leukemia 2001; 15: 1415-23.
30. Moreau EJ, Langerak AW, van Gastel-Mol EJ, Wolvers-Tettero IL, Zhan M, Zhou Q, Koop BF, van Dongen JJ. Easy detection of all T cell receptor gamma (TCRG) gene rearrangements by Southern blot analysis: recommendations for optimal results. Leukemia 1999; 13: 1620-6.
31. Langerak AW, Wolvers-Tettero IL, van den Beemd MW, van Wering ER, Ludwig WD, Hahlen K, Necker A, van Dongen JJ. Immunophenotypic and immunogenotypic characteristics of TCRγδ T cell acute lymphoblastic leukemia. Leukemia 1999; 13: 206-14.
32. Szczepanski T, van der Velden VH, Raff T, Jacobs DC, van Wering ER, Bruggemann M, Kneba M, van Dongen JJ. Comparative analysis of T-cell receptor gene rearrangements at diagnosis and relapse of T-cell acute lymphoblastic leukemia (T-ALL) shows high stability of clonal markers for monitoring of minimal residual disease and reveals the occurrence of second T-ALL. Leukemia 2003; 17: 2149-56.
33. Steenbergen EJ, Vertagen OJ, van Leeuwen EF, von dem Borne AE, van der Schoot CE. Distinct ongoing ig heavy chain rearrangement processes in childhood b-precursor acute lymphoblastic leukemia. Blood 1993; 82: 581-9.
34. Hoffbrand V, Foroni L. Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. Best Practice & Research Clin Haemat 2002; 15: 71-90.
35. Camera A, Pezzullo L, Villa MR, Luciano L, Pane F, Izzo B, Boccuni P, Di Noto R, Del Vecchio L, Salvatore F, Rotoli B. Coexistence of two distinct cell populations (CD56+TcRγδ+ and CD56+TcRγδ-) in a case of aggressive CD56+ lymphoma/ leukemia. Haematologica 2000; 85: 496-501.
36. nd relapse of childhood precursor B-cell acute lymphoblastic leukemia. Haematologica 2003; 88: 736-46.
37. Pine SR, Wiemels JL, Jayabose S, Sandoval C. TELAML1 fusion precedes differentiation to pre-B cells in childhood acute lymphoblastic leukemia. Leuk Res 2003; 27: 155-64.
38. van Dongen JJ, Seriu T, Panzer-Grumayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does-van den Berg A, Hop WC, Riehm H, Bartram CR. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 1998; 28: 1731-8.